Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Adherium Ltd. ( (AU:ADR) ) has shared an update.
Adherium Limited has announced a proposed issue of securities through an accelerated non-renounceable entitlement offer. This initiative involves issuing up to 800 million unlisted options over shares, exercisable at $0.005, with expiration dates in 2026. The offer aims to strengthen the company’s capital base and support its strategic growth initiatives, potentially impacting its market positioning and stakeholder interests.
More about Adherium Ltd.
Adherium Limited operates in the healthcare industry, focusing on providing digital health solutions. The company specializes in developing and manufacturing connected devices and software to enhance medication adherence, primarily targeting respiratory conditions such as asthma and COPD.
Average Trading Volume: 107,044
Technical Sentiment Signal: Sell
Current Market Cap: A$5.31M
See more data about ADR stock on TipRanks’ Stock Analysis page.